Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO. Kass MA, et al. Among authors: miller jp. Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30. doi: 10.1001/archopht.120.6.701. Arch Ophthalmol. 2002. PMID: 12049574 Clinical Trial.
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension.
Ocular Hypertension Treatment Study Group; European Glaucoma Prevention Study Group; Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, Miller JP, Gao F, Adamsons I, Poli D, D'Agostino RB, Kass MA. Ocular Hypertension Treatment Study Group, et al. Among authors: miller jp. Ophthalmology. 2007 Jan;114(1):10-9. doi: 10.1016/j.ophtha.2006.08.031. Epub 2006 Nov 7. Ophthalmology. 2007. PMID: 17095090 Free PMC article.
Delaying treatment of ocular hypertension: the ocular hypertension treatment study.
Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR; Ocular Hypertension Treatment Study Group. Kass MA, et al. Among authors: miller jp. Arch Ophthalmol. 2010 Mar;128(3):276-87. doi: 10.1001/archophthalmol.2010.20. Arch Ophthalmol. 2010. PMID: 20212196 Free PMC article. Clinical Trial.
Evaluation of a Primary Open-Angle Glaucoma Prediction Model Using Long-term Intraocular Pressure Variability Data: A Secondary Analysis of 2 Randomized Clinical Trials.
Gordon MO, Gao F, Huecker JB, Miller JP, Margolis M, Kass MA, Miglior S, Torri V; European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study. Gordon MO, et al. Among authors: miller jp. JAMA Ophthalmol. 2020 Jul 1;138(7):780-788. doi: 10.1001/jamaophthalmol.2020.1902. JAMA Ophthalmol. 2020. PMID: 32496526 Free PMC article. Clinical Trial.
Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.
Kass MA, Heuer DK, Higginbotham EJ, Parrish RK, Khanna CL, Brandt JD, Soltau JB, Johnson CA, Keltner JL, Huecker JB, Wilson BS, Liu L, Miller JP, Quigley HA, Gordon MO; Ocular Hypertension Study Group. Kass MA, et al. Among authors: miller jp. JAMA Ophthalmol. 2021 Apr 15;139(5):1-9. doi: 10.1001/jamaophthalmol.2021.0341. Online ahead of print. JAMA Ophthalmol. 2021. PMID: 33856434 Free PMC article.
838 results